Skip to main content
Clinical Trials/NCT04029727
NCT04029727
Completed
Not Applicable

Pilot Study to Evaluate the Effect of the Consumption of a Combination of Plant Extracts (BSL_EP025) on the Levels of LDL-cholesterol and Oxidized LDL-cholesterol in Healthy Volunteers

Biosearch S.A.1 site in 1 country40 target enrollmentMay 24, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Disease
Sponsor
Biosearch S.A.
Enrollment
40
Locations
1
Primary Endpoint
LDL cholesterol
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The objective of the study is to evaluate the ability of a combination of plant extracts (BSL_EP025) to reduce the levels of LDL-cholesterol and oxidized LDL-cholesterol in individuals with LDL-cholesterol levels between 100 and 190 mg/dL.

Detailed Description

There is a strong relationship between serum cholesterol levels and cardiovascular diseases, especially between coronary artery disease and LDL-cholesterol (LDL). LDL is the lipoprotein responsible for delivering cholesterol to cells. However, in recent years, special attention has been given to modified LDL, especially oxidized LDL, since it plays a very important role in the initiation and progression of the atheroma plaque. There are environmental and genetic factors that can influence the type and levels of blood lipoproteins. Among the modulable factors (environmental) it has been observed that some phytochemical compounds found in several plant extracts may reduce cardiovascular risk, due to their antioxidant and anti-inflammatory properties. The objective of the present study is to evaluate the possible effect of the intake of a combination of plant extracts (BSL_EP025) on the levels of LDL-cholesterol and oxidized LDL-cholesterol in healthy individuals with LDL-cholesterol levels between 100 and 190 mg/dL.

Registry
clinicaltrials.gov
Start Date
May 24, 2019
End Date
July 31, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Biosearch S.A.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Men or women between 18 and 65 years of age.
  • Levels of LDL-cholesterol between 100 and 190 mg/dL.
  • Accept freely to participate in the study and sign the informed consent document.

Exclusion Criteria

  • Be pregnant.
  • Have planned to carry out a dietary intervention or exercise practice with the aim of losing weight in the coming weeks.
  • Suffer from a serious illness.
  • Have diabetes.
  • Having a cerebrovascular disease.
  • Be taking products or drugs to control cholesterol levels or with antioxidant activity.

Outcomes

Primary Outcomes

LDL cholesterol

Time Frame: 8 weeks

Levels of LDL cholesterol in plasma

Oxidized LDL cholesterol

Time Frame: 8 weeks

Levels of oxidized LDL cholesterol in plasma

Secondary Outcomes

  • Triglycerides(8 weeks)
  • Glucose(8 weeks)
  • Beta IL-1(8 weeks)
  • IL-6(8 weeks)
  • ICAM-1(8 weeks)
  • IL-10(8 weeks)
  • Total cholesterol(8 weeks)
  • HDL cholesterol(8 weeks)
  • Blood pressure(8 weeks)
  • Body mass index(8 weeks)
  • VCAM-1(8 weeks)

Study Sites (1)

Loading locations...

Similar Trials